Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2015 1
2016 1
2017 3
2021 1
2023 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
The EPIC study: a lesson to learn.
Auerswald G, Kurnik K, Aledort LM, Chehadeh H, Loew-Baselli A, Steinitz K, Reininger AJ; EPIC clinical study group. Auerswald G, et al. Haemophilia. 2015 Sep;21(5):622-8. doi: 10.1111/hae.12666. Epub 2015 Apr 23. Haemophilia. 2015. PMID: 25912619 Clinical Trial.
[Efficiency of the ALL-MB-2002 protocol in children with acute lymphoblastic leukemia].
Rumiantseva IuV, Karachunskiĭ AI, Aleĭnikova OV, Fechina LG, Shamardina AV, Litvinov DV, Ponomareva NI, Boĭchenko EG, Dudkin SA, Streneva OV, Kondratchik KL, Mansurova EG, Minkina LM, Lapotentova ES, Iniushkina EV, Iudina NB, Pavlova GP, Zhukovskaia EV, Khlebnikova OP, Lagoĭko SN, Basharova EV, Denisov RE, Zlobina VD, Banshchikova ES, Aslanian KS, Kondakova EV, Tselousova EV, Miakova NV, Turobova TV, Ryskal' OV, Chipsanova NF, Varfolomeeva SR, Rumiantsev AG. Rumiantseva IuV, et al. Among authors: basharova ev. Ter Arkh. 2010;82(7):11-9. Ter Arkh. 2010. PMID: 20853603 Clinical Trial. Russian.
Palonosetron versus ondansetron for prevention of chemotherapy-induced nausea and vomiting in paediatric patients with cancer receiving moderately or highly emetogenic chemotherapy: a randomised, phase 3, double-blind, double-dummy, non-inferiority study.
Kovács G, Wachtel AE, Basharova EV, Spinelli T, Nicolas P, Kabickova E. Kovács G, et al. Among authors: basharova ev. Lancet Oncol. 2016 Mar;17(3):332-344. doi: 10.1016/S1470-2045(15)00520-3. Epub 2016 Jan 19. Lancet Oncol. 2016. PMID: 26795844 Free article. Clinical Trial.